13 MAR 2011

• Donation of Goods to Disaster Victims of the Tohoku Earthquake

14 JUN 2013 [Pharmaceuticals]

• A New Choice of Therapy for the Treatment of Depression: ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatment of Depression in Japan

10 JUN 2013 [Nutraceuticals]

• The No.1 pharmacist-recommended supplement「Nature Made, The First Supplement Facility was Built in Alabama, Production Capacity Increases 40% by 2014

7 JUN 2013 [Corporate]

• Otsuka has been selected by METI, as a model enterprise for business continuity management

3 JUN 2013 [Pharmaceuticals]

• Otsuka Pharmaceutical Submits New Drug Application in Japan for Tolvaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

3 JUN 2013 [Pharmaceuticals]

• Vasopressin V2 Receptor Antagonist Samsca® 7.5mg Tablets To Be Launched in Japan on June 4 – Additional Choice of Dose for the Treatment of Volume Overload in Patients with Heart Failure